Abstract
Carbon nanotubes have shown broad potential in biomedical applications, given their unique mechanical, optical, and chemical properties. Functionalized carbon nanotubes not only can deliver drug into specific organs but also can inherently produce heating by near-infrared laser radiation for cancer therapy. However, the toxicological and pharmacological profile of such carbon nanotube system will have to be determined prior to any clinical study undertaken. For providing a guide to develop safe drug carriers, this review discusses the functionalization, toxicity and pharmacokinetics of carbon nanotubes. Lastly, the drug delivery and thermal ablation on carbon nanotubes are proposed.
Keywords: Carbon nanotubes, toxicity, biodistribution, pharmacokinetics.
Current Drug Metabolism
Title:The Toxicity and Pharmacokinetics of Carbon Nanotubes as an Effective Drug Carrier
Volume: 14 Issue: 8
Author(s): En Luo, Guodong Song, Yunfeng Li, Pengwei Shi, Jing Hu and Yunfeng Lin
Affiliation:
Keywords: Carbon nanotubes, toxicity, biodistribution, pharmacokinetics.
Abstract: Carbon nanotubes have shown broad potential in biomedical applications, given their unique mechanical, optical, and chemical properties. Functionalized carbon nanotubes not only can deliver drug into specific organs but also can inherently produce heating by near-infrared laser radiation for cancer therapy. However, the toxicological and pharmacological profile of such carbon nanotube system will have to be determined prior to any clinical study undertaken. For providing a guide to develop safe drug carriers, this review discusses the functionalization, toxicity and pharmacokinetics of carbon nanotubes. Lastly, the drug delivery and thermal ablation on carbon nanotubes are proposed.
Export Options
About this article
Cite this article as:
Luo En, Song Guodong, Li Yunfeng, Shi Pengwei, Hu Jing and Lin Yunfeng, The Toxicity and Pharmacokinetics of Carbon Nanotubes as an Effective Drug Carrier, Current Drug Metabolism 2013; 14 (8) . https://dx.doi.org/10.2174/138920021131400110
DOI https://dx.doi.org/10.2174/138920021131400110 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Docking Modelling Rationally Predicts Strong Binding of Bisphenol A to Estrogen-Related Receptor γ
Protein & Peptide Letters Role of Secondary Alcohol Metabolites in Anthracycline Cardiotoxicity: from Hypotheses to New Drugs
Drug Design Reviews - Online (Discontinued) Dietary Small Molecules and Large-Scale Gene Expression Studies: An Experimental Approach for Understanding their Beneficial Effects on the Development of Malignant and Non-Malignant Proliferative Diseases
Current Medicinal Chemistry Direct Analysis of Glucuronides with Liquid Chromatography-Mass Spectrometric Techniques and Methods
Current Drug Metabolism Phenolic Compounds: the Role of Redox Regulation in Neurodegenerative Disease and Cancer
Mini-Reviews in Medicinal Chemistry Current Advances in Vehicles for Brain Gene Delivery
Current Gene Therapy The Role of Oxidative Stress Modulators in Breast Cancer
Current Medicinal Chemistry Anticancer Activity of an Oplopanax elatus Stem Extract and Biologically Active Isolated Compounds
Current Pharmaceutical Biotechnology Natural Products Containing Olefinic Bond: Important Substrates for Semi-synthetic Modification Towards Value Addition
Current Organic Chemistry Soy and Its Isoflavones: The Truth Behind the Science in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Antioxidant Supplementation on Cancer Risk and During Cancer Therapy: An Update
Current Topics in Medicinal Chemistry MEK Inhibition Increases Lapatinib Sensitivity Via Modulation of FOXM1
Current Medicinal Chemistry Serum Free or Not: Two Distinct Recycling Mechanisms Mediated by Alpha v Beta 3 Integrin
Current Pharmaceutical Biotechnology Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Current Cancer Drug Targets Review of Theoretical Studies for Prediction of Neurodegenerative Inhibitors
Mini-Reviews in Medicinal Chemistry FLT3 as a Therapeutic Target in Childhood Acute Leukemia
Current Drug Targets Treatment Modalities for Hepatocellular Carcinoma
Current Cancer Drug Targets Autophagy Driven Extracellular Vesicles in the Leukaemic Microenvironment
Current Cancer Drug Targets Recent Advances in the Synthesis and Application of Bismuth-Containing Heterocyclic Compounds
Current Organic Chemistry